Healthcare Sector

ABBV

Market Tracker

$172.45
+1.09
(+0.64%)
9:45 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • ABBV (Selected)

    AbbVie Inc.

ABBV Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

ABBV Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

ABBV Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

ABBV Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

ABBV Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

ABBV Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/02/2024 CALL $175.00 583 +553 +1,843.33%
03/21/2025 PUT $160.00 753 +500 +197.63%
09/20/2024 PUT $175.00 788 +314 +66.24%
07/19/2024 CALL $175.00 1,377 +272 +24.62%
06/28/2024 CALL $172.50 316 +238 +305.13%
09/20/2024 CALL $180.00 2,950 +226 +8.30%
06/21/2024 CALL $172.50 1,072 -55 -4.88%
06/28/2024 CALL $170.00 754 -65 -7.94%
09/20/2024 CALL $160.00 1,871 -111 -5.60%
08/16/2024 CALL $170.00 2,089 -244 -10.46%
06/21/2024 CALL $170.00 6,326 -403 -5.99%
06/21/2024 CALL $165.00 5,399 -657 -10.85%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

ABBV Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 53.76M 7.26B
Vanguard 500 Index Fund 2.32% 40.88M 5.52B
Fidelity 500 Index Fund 1.10% 19.39M 2.62B
SPDR S&P 500 ETF Trust 1.09% 19.15M 2.58B
American Mutual Fund Inc 1.00% 17.6M 2.38B
iShares Core S&P 500 ETF 0.89% 15.78M 2.13B
Vanguard Index-Value Index Fund 0.87% 15.28M 2.06B
Capital Income Builder, Inc. 0.84% 14.87M 2.01B
Select Sector SPDR Fund-Health Care 0.81% 14.36M 1.94B
Washington Mutual Investors Fund 0.75% 13.22M 1.78B

ABBV News

  • 10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year

    06/20 08:41 am

    The Motley Fool

    Read more
  • Why AbbVie (ABBV) is a Great Dividend Stock Right Now

    06/19 11:45 am

    Zacks Investment Research

    Read more
  • Here's Why AbbVie (ABBV) is a Strong Momentum Stock

    06/19 09:50 am

    Zacks Investment Research

    Read more
  • AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis

    06/19 08:45 am

    Zacks Investment Research

    Read more
  • 2 Super Smart Dividend Stocks to Buy With $10,000 Right Now

    06/19 04:19 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider

    06/18 05:45 pm

    Zacks Investment Research

    Read more
  • Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study

    06/18 10:22 am

    Zacks Investment Research

    Read more
  • 2 Dividend Stocks That Could Pay You for Life

    06/16 08:30 am

    The Motley Fool

    Read more
  • Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails

    06/14 09:05 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate

    06/14 08:50 am

    Zacks Investment Research

    Read more
  • AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

    06/12 09:00 am

    Zacks Investment Research

    Read more
  • Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now?

    06/11 06:20 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Laps the Stock Market: Here's Why

    06/10 05:45 pm

    Zacks Investment Research

    Read more
  • Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside

    06/07 02:30 pm

    Benzinga

    Read more
  • Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval

    06/07 10:20 am

    Zacks Investment Research

    Read more
  • AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal

    06/07 10:18 am

    Zacks Investment Research

    Read more
  • Forget SCHD: Buy Dividend Aristocrats Instead

    06/06 08:59 pm

    Seeking Alpha

    Read more
  • AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug

    06/06 11:53 am

    Zacks Investment Research

    Read more
  • 2 High-Yield Dividend Stocks to Buy Right Now

    06/05 09:30 am

    The Motley Fool

    Read more
  • Analyst Scoreboard: 6 Ratings For AbbVie

    06/05 08:01 am

    Benzinga

    Read more
  • Top Stocks to Buy in June

    06/04 08:52 am

    The Motley Fool

    Read more
  • AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

    06/03 05:45 pm

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Could Be a Great Choice

    06/03 11:45 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU

    06/03 10:05 am

    Zacks Investment Research

    Read more
  • Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

    06/03 06:20 am

    Zacks Investment Research

    Read more
  • AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?

    06/03 02:33 am

    Zacks Investment Research

    Read more
  • 3 No-Brainer Stocks to Buy in June

    06/02 06:00 am

    The Motley Fool

    Read more
  • Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal

    05/31 01:01 pm

    Zacks Investment Research

    Read more
  • Should Schwab U.S. Dividend Equity ETF (SCHD) Be on Your Investing Radar?

    05/31 06:20 am

    Zacks Investment Research

    Read more
  • 3 Dividend Stocks to Double Up on Right Now

    05/30 05:45 am

    The Motley Fool

    Read more
  • Are Options Traders Betting on a Big Move in AbbVie (ABBV) Stock?

    05/29 04:32 pm

    Zacks Investment Research

    Read more
  • Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar?

    05/29 06:20 am

    Zacks Investment Research

    Read more
  • Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows

    05/27 01:45 am

    Seeking Alpha

    Read more
  • Forget Nvidia, Buy This Magnificent Healthcare Stock Instead

    05/26 08:10 am

    The Motley Fool

    Read more
  • How To Invest $1 Million For Steady Income And Growth

    05/25 09:00 am

    Seeking Alpha

    Read more
  • Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever

    05/25 05:46 am

    The Motley Fool

    Read more
  • Sell Alert: 2 Dividend Stocks To Sell In May And Go Away

    05/24 11:03 am

    Seeking Alpha

    Read more
  • High Yields And Low Multiples - 3 Of My Favorite Dividend Stocks To Buy Right Now

    05/24 07:30 am

    Seeking Alpha

    Read more
  • Why AbbVie (ABBV) is a Top Value Stock for the Long-Term

    05/23 09:40 am

    Zacks Investment Research

    Read more
  • Lilly (LLY) Hits Record High on Crohn's Disease Study Data

    05/22 01:16 pm

    Zacks Investment Research

    Read more
  • A Must-Own Stock for Any Portfolio

    05/22 08:42 am

    The Motley Fool

    Read more
  • 2 Billion More Reasons to Buy AbbVie Stock

    05/22 06:45 am

    The Motley Fool

    Read more
  • 1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?

    05/20 10:58 am

    The Motley Fool

    Read more
  • 10 Stocks to Build a Dividend Portfolio With

    05/18 08:21 am

    The Motley Fool

    Read more
  • AbbVie Is 'Successfully Positioned To Absorb Humira Biosimilar Erosion': Analyst

    05/17 01:47 pm

    Benzinga

    Read more
  • The Analyst Verdict: AbbVie In The Eyes Of 5 Experts

    05/17 09:00 am

    Benzinga

    Read more
  • Are You Looking for a High-Growth Dividend Stock?

    05/16 11:45 am

    Zacks Investment Research

    Read more
  • Pfizer: Best Trading Momentum Since 2021 And 6% Yield

    05/15 08:45 am

    Seeking Alpha

    Read more
  • Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In

    05/14 01:32 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: